“Meth” is back and more deadly than ever… who’s at risk?

Sharon Kelley | GAPA 2020 Summer CME Conference

Written by: Sharon Kelley, PhD, MS

Methamphetamine abuse is soaring and is often being combined with the deadly opioid fentanyl.  Between 2013 and 2019, urine samples testing positive for both methamphetamine and fentanyl increased approximately 14-fold.

Medical providers have a reason for concern that this trend may continue as reported in the Jan. 3rd issue of JAMA Network Open.  Specific concerns include CNS depression but also CNS stimulation resulting in negative cardiovascular and cerebral events.   Long term sequelae of methamphetamine abuse are associated with psychosis and violent behavior and therefore an additional concern for medical providers.

For more information on Methamphetamine abuse, see Sharon Kelley, PhD, MS speak at the GAPA 2020 Summer Conference in Sandestin, Florida.

Share this story:

Share on Facebook Share on Twitter Share on LinkedIn Email to a Friend
GAPA